Navigation Links
Nonmedicinal treatment touted for preschoolers with ADHD
Date:8/21/2007

ial skills. Teachers saw similarly strong results; in the classroom, there was a 28-percent improvement in both categories. Early literacy skills improved up to three times over their baseline status.

Medication may address the symptoms of ADHD, says DuPaul, but it does not necessarily improve childrens academic and social skills. And because this is a lifelong disorder, without any cure, its important that we start understanding what tools and strategies are effective for children with ADHD at such an early age.

Theres simply a lack of understanding about the type of non-medicinal services that are available to preschool children and their families. Our goal is to address behavioral and academic issues before they become more problematic in elementary school.

Early intervention techniques include highly individualized programs that often rely on positive supports to reinforce behavior. For example, in consultation with parents and preschool teachers, Project Achieve researchers modified the environments in home and school (such as altering tasks and activities in the classroom to accommodate for ADHD students) in an effort to improve behavior. The highly interactive techniques were presented as alternatives to medicine.

ADHD is a lifelong mental disorder that may become apparent in a childs formative preschool years. The disorder, which makes it difficult for children to control their behavior and pay attention, affects about 7 percent of the school-aged population. The disorder has become a public health concern, however, because 40 percent of children who show signs of ADHD are suspended from preschool, while approximately 16 percent are eventually expelled.

The researchers suggest that a multi-tiered approach to intervention, offering more traditional services to at-risk children and more intensive services to children in greatest need, may be the most practical and cost-effective strategy for helping preschoolers ov
'/>"/>

Contact: Tom Yencho
yenchot@lehigh.edu
610-758-3172
Lehigh University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. Now umbilical cord helps in stroke treatment.
6. Now AIDS treatment comes dirt-cheap
7. Breast cancer treatment to be determined by gene test
8. Hemopurifier may revolutionise AIDS treatment
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...e disgraced stem-cell scientist has been suspended...006, along with six other researchers. This measur... regard to their research work.// The seven profes...ng at the university or conducting research. They ...
...cy across the world is increasing, and it is estim...in their 30s will live to see their 100th birthday...n of centenarians is expected to soar from the pre...y 2074 in Britain, according to the Daily Mail. ...
...ernment has been called upon to provide better inc...e pharmacies. More people are being turned away as...gram, for which the Government has been faulted. /...r has revealed that the program has the involvemen...
... offered by generic drug makers may well eat into ...o company sources. The Cox-2 painkiller of the org...this.// The company is also embroiled in a tax rel...sales of the company for the year rose by13% at ?2...
Other Medicine News:
(Date:9/4/2008)...e/ -- Cytopia Limited (ASX:,CYT) today announced t...,study of CYT997, the company,s novel vascular-dis...essive form of brain cancer known as glioblastoma,...first Phase II efficacy study in highly,vascular, ...cond in its,suite of Phase II studies designed to ...
(Date:9/4/2008)...resented at ESC Congress-, PHILADELPHIA, Sept. 4 ...tudy, the GISSI Heart Failure (GISSI-HF) study, sh...reduced all cause mortality and hospital,admission...nic heart,failure. These findings are published in...re presented at the European Cardiovascular Societ...
(Date:9/4/2008)...wire/ -- Axentis Pharma AG has,initiated a clinica...ility,of a new therapeutic formulation for the tre...rosis patients. The new formulation allows an,esta... to the site of,infection. The forthcoming trial w...s of the new drug. Initial results are expected in...
(Date:9/4/2008)...h Two Abstracts Accepted for Presentation, and...IDGEWATER, N.J., Sept. 4 /- Aegerion ...company focused on the treatment of,cardiovascular...tment of,Peter L. Garrambone, Jr. to the Company,s...ncludes more than 50 pharmaceutical,transactions e...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Wisconsin researchers describe how digits grow 2471 1Wisconsin researchers describe how digits grow 2471 2Wisconsin researchers describe how digits grow 2471 3BioAnalytics Group CEO Senior Scientist to Present at Tucson Symposium March 12 13 3875 1BioAnalytics Group CEO Senior Scientist to Present at Tucson Symposium March 12 13 3875 2Penn research offers road map to safer pain control cost savings during colonoscopies 14067 1Penn research offers road map to safer pain control cost savings during colonoscopies 14067 2Policing cells demand ID to tell friend from foe say University of Pennsylvania cell engineers 2467 1Policing cells demand ID to tell friend from foe say University of Pennsylvania cell engineers 2467 2
...INESS WIRE)--Mar 20, 2007 - MGI PHARMA, INC.,(NASD...oncology and,acute care, today announced that a ra...e 3 trial of Aquavan(R) (fospropofol,disodium) Inj...scopy successfully met its primary endpoint of sed...Among patients who,received an initial bolus dose ...
...eased Enzyme Levels in Two Most Common Mutations, ...cus,Therapeutics, a biopharmaceutical company deve...ological chaperones for the,treatment of a range o...will present the results of preclinical studies of...ucher disease at,the of Medical Genetics (ACMG) an...
Other Medicine Technology:MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 2MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 3MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 4MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 5MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy 6Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 2Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 3
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: